Good manufacturing practices for cell and gene therapies: an interview with Craig Hasilo

Written by RegMedNet

In this interview, Craig Hasilo (CellCAN, Montréal, Canada) provides us with an overview of the advanced training offers that CellCAN provides on good manufacturing practices (GMPs) for cell and gene therapies (CGTs). He also discusses how the manufacturing practices of CGTs could be kept consistent to ensure that quality, safety and feasibility are maintained, in addition to providing his thoughts on how challenges surrounding implementation could be addressed. Please can you introduce yourself and tell us more about CellCAN? My name is Craig Hasilo. I’m the Chief Scientific Officer at CellCAN. My doctoral studies in Experimental Surgery at McGill University...

To view this content, please register now for access

It's completely free